In a statement dated 8 March 2023, Helen Knight, director of medicines evaluation at NICE, said: Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years. Commenting on the guidance, Hannah Beba, consultant diabetes pharmacist for NHS Leeds Clinical Commissioning Group, said she had some reservations around the often relapsing nature of obesity and the provision of only a two-year access to the medication
Effects of L-citrulline supplementation on endothelial function and blood pressure in hypertensive postmenopausal women
Known for its profound regenerative potential, BPC supports tissue healing far beyond the gutbenefiting tendons, ligaments, vasculature, the nervous system, and more
Reducing inflammatory signaling may protect tissues even without acting directly on muscle or liver cells
Clinical Update 9/06/2017 Turmeric for Arthritis
Retatrutide vs Semaglutide: A Generation Apart Semaglutide revolutionized obesity treatment when it launched, but the gap between single and triple agonist therapy has become substantial
